North America Peptide Therapeutics Market Size & Outlook
Related Markets
North America peptide therapeutics market highlights
- The North America peptide therapeutics market generated a revenue of USD 87,315.5 million in 2025.
- The market is expected to grow at a CAGR of 9.9% from 2026 to 2033.
- In terms of segment, metabolic disorders was the largest revenue generating application in 2025.
- Metabolic disorders is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 87,315.5 million |
| Market revenue in 2033 | USD 199,806.7 million |
| Growth rate | 9.9% (CAGR from 2026 to 2033) |
| Largest segment | Metabolic disorders |
| Fastest growing segment | Metabolic disorders |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gastrointestinal disorders, Cancer, Metabolic disorders, Cardiovascular disorders, Pain, Respiratory disorders, Infectious disease, Dermatological disorders, Renal disorders, Neurological disorders |
| Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Amgen Inc, Takeda Pharmaceutical Co Ltd, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Sanofi SA, Roche Holding AG, Novartis AG ADR, Novo Nordisk A/S ADR, GlaxoSmithKline, Ironwood Pharmaceuticals Inc Class A, Ipsen SA, Radius Health |
Other key industry trends
- In terms of revenue, North America region accounted for 62.0% of the global peptide therapeutics market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- North America is the fastest growing regional market and is projected to reach USD 199,806.7 million by 2033.
Metabolic disorders was the largest segment with a revenue share of 77.35% in 2025. Horizon Databook has segmented the North America peptide therapeutics market based on gastrointestinal disorders, cancer, metabolic disorders, cardiovascular disorders, pain, respiratory disorders, infectious disease, dermatological disorders, renal disorders, neurological disorders covering the revenue growth of each sub-segment from 2021 to 2033.
North America leads the global peptide therapeutics market in terms of revenue generation, owing to the launch of effective products along with technologically advanced production facilities across the region. In addition, the increasing prevalence of diseases, such as cancer, cardiovascular disorders, respiratory diseases, infectious diseases, metabolic disorders, and others, is expected to drive market growth.
A large population is prone to major target diseases, which increases the need to develop effective therapeutics to curb their prevalence and enable effective management. Key players operating in the market are constantly focusing on product launches, collaborations, and partnerships to meet the rising demand among the population.
Both companies have been long-term partners of PeptiDream. Furthermore, the market in the region is anticipated to grow due to rising investments in the R&D of novel drugs and technological advancements pertaining to the development of effective therapeutics.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Therapeutics Market Scope
Peptide Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Radius Health | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://www.radiuspharm.com |
| Ironwood Pharmaceuticals Inc Class A | View profile | 267 | 100 Summer Street, Suite 2300, Boston, MA, United States, 02110 | https://www.ironwoodpharma.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Ipsen SA | View profile | 5325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | https://www.ipsen.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
North America peptide therapeutics market size, by country, 2021-2033 (US$M)
North America Peptide Therapeutics Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
